SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.

   Biotech / MedicalImmunomedics (IMMU) - moderated


Previous 10 Next 10 
To: ipeefreely who wrote (49670)1/23/2019 2:27:11 PM
From: jargonweary
2 Recommendations   of 53464
 
"I'm a little confused..."

Well, sowing confusion does seem to be the idea for some.

Share RecommendKeepReplyMark as Last Read


To: ladyPI who wrote (49660)1/23/2019 2:45:05 PM
From: EMU2
1 Recommendation   of 53464
 
If you, with confidence, could say "I know" the company wouldn't mind, Instead of saying, "I believe" the company wouldn't mind. It would make others feel more at ease.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: ipeefreely who wrote (49665)1/23/2019 2:55:59 PM
From: li3511
2 Recommendations   of 53464
 
> In other news, how'd you find the time to count his post? Or is there some faster way to do it. I'm genuinely curious...

Cut and paste into Microsoft Word. It's trivial to get a word count.

Share RecommendKeepReplyMark as Last Read


To: czboy who wrote (49667)1/23/2019 2:59:31 PM
From: li3511
15 Recommendations   of 53464
 
> CRL means " rejection" , the magt may need to overhaul the whole manufacturing procedure.

Get a clue: The people on this board aren't idiots, and this nonsense isn't anywhere near true.

Share RecommendKeepReplyMark as Last Read


To: MFG ENG who wrote (49672)1/23/2019 3:00:41 PM
From: rodneyh07
   of 53464
 
It’s all possible.....again we are judging and that’s not our job.

One year will be this August and falls under what other well respected people on this board has more or less said....

Share RecommendKeepReplyMark as Last Read


To: czboy who wrote (49675)1/23/2019 3:02:59 PM
From: li3511
10 Recommendations   of 53464
 
> The CRL is a total rejection of their manufacturing scheme: "chemistry " , "data integrity " could be very serious .

Complete nonsense. The manufacturing scheme for monoclonal antibodies is pretty much cookbook these days.

Share RecommendKeepReplyMark as Last Read


To: JJINV who wrote (49663)1/23/2019 3:06:18 PM
From: EMU2
1 Recommendation   of 53464
 
Let me refer to kdd999's post # 49613. Which is from his research of FDA CRLs

The FDA never publicly discusses a CRL and companies never convey complete info about a CRL.

He goes on to explain why

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: EMU2 who wrote (49682)1/23/2019 3:34:34 PM
From: allatwwk
   of 53464
 
Collectively, what we don't know about the CRL and next steps is a whole more than what we do know.

IMMU doesn't know enough either, that's why they need the meeting. They don't know if they'll need a category 1 or 2 submission -- that itself is telling.

At this point, there are a few things people do know. There is a range of scenarios for getting 132 approved, some are a matter of months, others could run out to around a year. We have a realistic range of possibilities. We believe that the FDA believes132 works well enough to approve before the phase 3 data is complete - an approval which can be rescinded if the phs 3 results are insufficient.

We don't know the 'real-world' severity of the CMC issues raised in the CRL. Again, IMMU isn't really sure on this front. The one read into this came from Morgan Stanley. But we also know Pehl misread the tea leaves before, so even this take isn't so trustworthy.

We have the mgmt team we have. Some will trust them, some will not. The Morgan Stanley report was comforting, but they also cut the target share price (was $38 I think) more than in half ($17). And they lowered their upside forecast to $25. Did failing AA all of a sudden make 132 worth half of what it was? I don't think so. And yet, a major analyst slashed everything.

We'll know a lot more by the actions we see next. If the company goes into cash preservation mode, it means they believe this could take a while. If they get rid of Morris (the CMC guy), it means they've lost confidence in his ability to get manufacturing right. If Pehl goes, it'd suggest iMMU is up for sale -- they can't afford to be without a CEO in this period.

For me, I'm going to trust this management team, but keep my grain of salt handy. Yes they missed and the miss matters a lot. But they can correct and get the company back on track. I don't think the share price will be happy until after an approval, so I suspect IMMU is a trading stock until the FDA says 'approved' or 'not' on the next submission.

Lastly, I wondered if we'd hit 50,000 comments before IMMU got an approval or after. I'm afraid its gonna be after ...

Share RecommendKeepReplyMark as Last Read


To: czboy who wrote (49667)1/23/2019 3:55:39 PM
From: drtom1234
3 Recommendations   of 53464
 
Ok, Mr. I just-joined-the-board today. I will definitely take your opinion seriously.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


From: ghettogoulash1/23/2019 4:03:15 PM
4 Recommendations   of 53464
 
MFG ENG, I feel you have made a valuable contribution. I'm sure others do, too.

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10